Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Prolymphocytic, T-Cell × ibrutinib × 30 days × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 17 Lymphoma, Mantle-Cell 7 Lymphoma, Non-Hodgkin 6 Lymphoma, Large B-Cell, Diffuse 6 Waldenstrom Macroglobulinemia 3 Neoplasms 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma 3 Recurrence 2 Lymphoma, B-Cell 2 Leukemia, Hairy Cell 2 Burkitt Lymphoma 2 Prostatic Neoplasms, Castration-Resistant 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Myelodysplastic Syndromes 1 Lymphoproliferative Disorders 1 Lymphoma, AIDS-Related 1 Lymphatic Diseases 1 Leukemia, Prolymphocytic 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphoid 1 Leukemia, B-Cell 1 Immunoproliferative Disorders 1 Immune System Diseases 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Bronchiolitis Obliterans Syndrome 1

Interventions

ruxolitinib 2 duvelisib 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡